SCHEMBL8639290

SCHEMBL8639290

Cc1ccccc1S(=O)(=O)OCCCc1ccc(C(C(=O)O)C2CCCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 2/20 0.41
ALOX5 P09917 2/20 0.39
HDAC6 Q9UBN7 1/20 0.39
CYP3A4 P08684 2/20 0.39
CHRM2 P08172 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
CHRM1 P11229 1/20 0.39
DRD1 P21728 1/20 0.39
SLC6A2 P23975 1/20 0.39
ADRA1A P35348 1/20 0.39
OPRM1 P35372 1/20 0.39
DRD3 P35462 1/20 0.39
SLC6A3 Q01959 1/20 0.39
KCNH2 Q12809 1/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
FKBP1A P62942 5/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8637023 0.94 ALOX5 (0.40) CHRM3ALOX5HDAC6CYP3A4CHRM2
SCHEMBL9010367 0.83 FKBP1A (0.40) CHRM3ALOX5HDAC6FKBP1A
SCHEMBL8637017 0.79 ALOX5 (0.41) CHRM3ALOX5HDAC6CYP3A4CHRM2
SCHEMBL8636307 0.73 CHRM3 (0.49) CHRM3ALOX5HDAC6CYP3A4LMNA
SCHEMBL8634916 0.70 CHRM3 (0.47) CHRM3ALOX5HDAC6LMNA
SCHEMBL6912266 0.70 CA1 (0.54) LMNACYP1A2
SCHEMBL8637021 0.69 HPGD (0.39) CYP1A2THRB
SCHEMBL7619544 0.69 KMT2A (0.43) LMNACYP1A2
SCHEMBL27483589 0.69 CHRM3 (0.46) CHRM3ALOX5HDAC6CYP3A4CHRM2
SCHEMBL27388408 0.69 CHRM3 (0.46) CHRM3ALOX5HDAC6CYP3A4CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5776964-A HYPOTENSIVE AGENTS; ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 1998-07-07 US disclosed
US-5521206-A HYPOTENSIVE AGENTS, TREATMENT OF ATHEROSCLEROSIS BAYER AKTIENGESELLSCHAFT (DE) 1996-05-28 US disclosed